Cormorant Private Healthcare Fund III LP is 10% Owner at Ambrx Biopharma Inc. (AMAM). They have made 4 open-market trades across 3 companies since 2023, most recently 2025-05-15.
CIK 0001817320
2 open-market purchases totalling $60.9M since 2023, against 2 sales. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.